Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)

Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)

Objective To assess the rates of vascular thrombotic adverse events in the first 35 days after one dose of the Ad26.COV2.S vaccine (Janssen/Johnson & Johnson) in healthcare workers in South Africa and to compare these rates with those observed in the general population.Design Open label, sin...

Full description

Saved in:
Bibliographic Details
Main Authors: Linda-Gail Bekker, Glenda Gray, Nigel Garrett, Ameena Goga, Amber Khan, Ishen Seocharan, Ian Sanne, Jonny Peter, Shirley Collie, Nonhlanhla Yende-Zuma, Barry Frank Jacobson, Elise Schapkaitz, Azwi Takalani, Jessica Opie, Tarylee Reddy, Michelle Robinson, Simbarashe Takuva, Pradeep Rowji, Vernon Johan Louw
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:BMJ Medicine
Online Access:https://bmjmedicine.bmj.com/content/2/1/e000302.full
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items